NOVEL IMMUNOTHERAPY FOR SEVERAL TUMORS OF BLOOD, IN PARTICULAR CHRONIC LYMPHATIC LEUKEMIA (CLL)

摘要

To provide peptides for use in immunotherapy.SOLUTION: The invention relates to peptides, nucleic acids and cells. In particular, the invention relates to cancer immunotherapy. The invention further relates to a tumor-associated cytotoxic T cell (CTL) peptide epitope that serves as an active pharmaceutical ingredient of a vaccine combination that stimulates anti-tumor immune response singly or in combination with another tumor associated peptides. The invention relates to several peptide sequences derived from human tumor cell HLA class I and HLA class II molecules and variants thereof usable in a vaccine composition for eliciting anti-tumor immune response.SELECTED DRAWING: None